Showing 1 - 10 of 115,953
pharmaceutical industry as well as the consumers in Canada. India has not yet been able to take full advantage of these provisions …. This paper is an attempt to make a parallel study of the pharma industry in India and Canada from the above mentioned …India has a thriving pharmaceutical industry dedicated to providing healthcare at the lowest possible cost. India …
Persistent link: https://www.econbiz.de/10014223100
/ A. Martinez -- The interplay between competition law and intellectual property : a perspective from Canada / A …. Gunderson -- The interplay between competition law and intellectual property : updates from India / N.S. Chopra & A.S. Sethi …
Persistent link: https://www.econbiz.de/10012216553
Persistent link: https://www.econbiz.de/10012518985
Persistent link: https://www.econbiz.de/10012302780
Persistent link: https://www.econbiz.de/10011548732
Persistent link: https://www.econbiz.de/10011588192
Persistent link: https://www.econbiz.de/10010247050
Persistent link: https://www.econbiz.de/10012433661
Canada is in the midst of negotiations over the Comprehensive Economic and Trade Agreement (CETA) with the European … intellectual property (IP) protection for pharmaceutical innovation. Canada faces pressure to enhance IP protection so that it more … closely aligns with protection that prevails in Europe and the United States, among other nations.The pressure for Canada to …
Persistent link: https://www.econbiz.de/10013076934
On 19 December 1997, the EC requested consultations with Canada in respect of the alleged lack of protection of … inventions by Canada in the area of pharmaceuticals under the relevant provisions of the Canadian implementing legislation, in … particular the Patent Act. The EC alleged that Canada’s legislation is not compatible with its obligations under the TRIPS …
Persistent link: https://www.econbiz.de/10012884077